Company intelligence / Profile preview

Hefei Huawei Pharmaceutical

Hefei, Anhui, China

Ownership: Private
Development stage: Other

Overview

Hefei Huawei Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates production lines that comply with Good Manufacturing Practice (GMP) standards, producing a variety of medications including tablets, capsules, and granules. Its product portfolio primarily addresses therapeutic areas such as gastroenterology, cardiovascular health, and anti-infectives. Hefei Huawei Pharmaceutical serves both domestic and international markets through its integrated manufacturing and distribution capabilities.

Therapeutic areas: GastroenterologyCardiovascularInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Hefei Huawei Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei Huawei Pharmaceutical.

Explore the full profile